Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Biotron ( (AU:BIT) ).
Biotron Limited has applied to the ASX for quotation of 292,666,664 new fully paid ordinary shares (ASX: BIT) and 146,333,324 options expiring 24 November 2027 (ASX: BITO), with an issue date of 30 January 2026. The move significantly increases the company’s quoted capital base and introduces a large tranche of listed options, which may provide additional funding flexibility and potential future dilution for existing shareholders while signalling an active phase of capital structuring and market engagement.
The most recent analyst rating on (AU:BIT) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Biotron stock, see the AU:BIT Stock Forecast page.
More about Biotron
Technical Sentiment Signal: Sell
Current Market Cap: A$8.43M
For an in-depth examination of BIT stock, go to TipRanks’ Overview page.